News Archive
CEO speaks at 25th Anniversary of PharmaZell plant in Chennai
Despite all restrictions and taking into account the COVID regulations, CEO Dr. Bolzern did not miss the opportunity to attend the celebration of the 25th anniversary of the PharmaZell Group...
CEO Appreciating COVID Warriors
CEO Dr. Oliver Bolzern visited the Visakhapatnam site in February. He appreciated the various measures and efforts taken during COVID pandemic which has helped to restrict any potential disturbance in...
PharmaZell – Update on new Mesalazine production building in Vizag (India)
We are pleased to share the last update on the construction of the new production building. The construction works are on schedule, three levels are already completed as shells. Looking...
Novel Food Ingredient registration – synthetic CBD
We are pleased to announce that the activities on synthetic CBD at our Farmabios site are progressing smoothly. The API is produced at a commercial batch size using a THC-free...
Private Equity owner Bridgepoint visits PharmaZell Group’s company Farmabios
In October 2020 our new investor Bridgepoint visited the Farmabios site in Gropello-Cairolli (Italy). Besides holding its regular board meeting, the attendees went on an extensive plant tour. They were...
FarmaBios – Update on construction of new steroid building in Gropello Cairoli (Italy)
The construction of the new steroid building is even in Covid-19 times running smoothly and almost on schedule. The department would have three layers for 980 m3 total with a...
FarmaBios – Update on new warehouse in Gropello Cairoli (Italy)
We are pleased to share the last updates on our new warehouse building, indeed the works are on schedule: the first storage racks have been already installed. The warehouse would...
UPDATE 4: IMPACT OF THE CURRENT COVID-19 OUTBREAK ON INDIAN PRODUCTION SITES
PharmaZell Group is very conscious of our important role and duty in delivering APIs to our customers and being an active part in maintaining the health system running. Up to...
FarmaBios activities are regularly proceeding…
During this critical and challenging period, Farmabios SpA states that our activities are regularly proceeding. We are conscious of the role and duty in delivering APIs, and our active part...
Breaking News: PharmaZell Group acquired by Bridgepoint
The PharmaZell Group management is very pleased to inform that the Group was acquired by Bridgepoint from DPE Deutsche Private Equity and Maxburg Capital Partners for an undisclosed sum. Bridgepoint...
Farmabios Breaks Ground to Expand its Manufacturing Footprint in Gropello Cairoli (Italy)
As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on...
Renewed GMP Certificate for our Manufacturing Facility Farmabios in Gropello Cairoli (Italy)
We are very glad to announce that the competent Italian authority (AIFA) has issued a renewed GMP certificate for our Farmabios SpA production facility [http://eudragmdp.ema.europa.eu/inspections/gmpc/generateGMPCPDF.do].
